Test May Help Spot Pancreatic Cancer
New Technique Uses Light to Check Cells Without Major Surgery
WebMD News Archive
Aug. 1, 2007 -- A new, no-surgery test may help detect pancreatic cancer in its earlier, more treatable stages, scientists announced today.
The test isn't ready for patients yet. But if successful in other studies, it may help people survive pancreatic cancer, which is America's fourth leading cause of cancer deaths.
The American Cancer Society predicts that this year in the U.S., about 37,170 people will be diagnosed with pancreatic cancer and about 33,370 will die of pancreatic cancer.
"One of the reasons for this grim prognosis for patients is that we still don't know how to detect it early enough," Northwestern University biomedical engineering professor Vadim Backman, PhD, said in a news conference today.
Early detection can make a big difference in survival, and Backman's team wants to improve patients' chances with their new test, which is described in today's edition of Clinical Cancer Research.
Pancreatic Cancer Theory
The scientists' theory boils down to this simple idea: When pancreatic cancer starts, there goes the neighborhood.
That is, pancreatic cancer is associated with subtle changes in neighboring cells in the duodenum, which is part of the small intestine.
Here's why that's important. Taking biopsies from the pancreas carries a high risk of complications. But the duodenum can be reached with a simple, nonsurgical procedure called an upper endoscopy.
In an upper endoscopy, doctors insert a thin tube into the sedated patient's mouth and guide the tube down the esophagus, through the stomach, and to the small intestine.
"It was, in a sense, a fishing expedition, because the pancreas and the duodenum are two different organs," Backman says. "There was a big question of if we would able to sense any differences in the otherwise normal duodenal tissue that would correlate with the presence of pancreatic cancer."
New Pancreatic Cancer Test
Backman's team gave upper endoscopies to 19 people who had already been diagnosed with pancreatic cancer and to 32 people without pancreatic cancer.
The scientists took small tissue samples (biopsies) from each person's duodenum and examined those biopsies in their lab.
This was no ordinary lab test. The researchers used a bright light and a special microscope to check for optical markers -- essentially, a fingerprint -- linked to pancreatic cancer.